GRIFOLS | GRF - Operating Profit


GRIFOLS reported EUR249M in Operating Profit for its fiscal quarter ending in March of 2026.





Operating Profit Change Date
Alcon AG USD 297M 16M Mar/2026
Almirall EUR 30.23M 12.8M Dec/2025
Amadeus IT EUR 491.1M 152.2M Mar/2026
Amarin USD -2.26M 564K Dec/2025
argenx SE USD 394M 22.86M Mar/2026
AstraZeneca USD 7.11B 4.14B Mar/2026
Bayer EUR 3.53B 2.42B Mar/2026
Cie Automotive EUR 264.84M 21.12M Dec/2025
Demant DKK 2.09B 224M Dec/2025
Ence Energia y Celulosa EUR -37.27M 22.77M Dec/2025
Essilor EUR 1.38B 626M Dec/2025
Ferrovial EUR 1000K 430M Dec/2025
Fresenius EUR 713M 139M Dec/2025
Fresenius Medical Care EUR 268M 395M Mar/2026
Genmab DKK 260M 199M Dec/2025
GlaxoSmithKline GBP 2.29B 856M Mar/2026
GRIFOLS EUR 249M 26.38M Mar/2026
Hikma Pharmaceutical USD 348M 161M Dec/2025
Inditex EUR 1.76B 298M Mar/2026
Lakefront Biotherapeutics EUR -63.7M 844.26M Mar/2026
Merck EUR 1.05B 572M Mar/2026
Novartis USD 4.24B 171M Mar/2026
Philips EUR 302M 417M Mar/2026
Roche Holding CHF 9.56B 3.8B Dec/2025
Sanofi EUR 1.94B 239M Mar/2026
Smith & Nephew USD 440M 50M Dec/2025
UCB EUR 1.29B 571M Dec/2025
Viscofan EUR 42.17M 8.14M Mar/2026